Dario Heymann, Ph.D

Chief Research Officer, Galen Growth

Singapore

Dario is founding member and Chief Research Offer of Galen Growth. He envisioned and built HealthTech Alpha; the world’s only venture aggregator, analytics platform and search engine dedicated to Digital Health. HealthTech Alpha currently holds more than 200M datapoints for more than 12,000 digital health ventures and 24,000 organisations active in digital health. HealthTech Alpha, remains the only true analytics platform for digital health, delivering accurate and regularly curated information to investors, industry innovation leaders and startup CxOs.

As well as managing the development of the analytics platform, Dario leads the research, market intelligence and client missions which helps inform and improve organisations’ overall digital health strategy by grounding decisions. Dario helps organisations and governments shape their Digital Health strategy and grow by providing insights and comprehensive sources, vital to monitor the pulse of the ecosystem and accelerate business strategies.

Prior to Galen Growth, Dario has worked in drug discovery mainly focused on the development of novel drugs in oncology, both in big pharma and academia in Singapore, China and Germany. Dario holds a doctorate in Material Science and Engineering and Masters in Material Science & Engineering, Biochemistry and Molecular Biology.